Joint ABCD & UKKA Meeting Abstracts | ABCD (Diabetes Care) Ltd

6th Joint Meeting of ABCD & UKKA - Abstracts

We are delighted to invite the submission of abstracts of no more than 250 words for the Joint Meeting of ABCD & UKKA.

Abstracts should be related to the care of people with diabetes and kidney disease and are welcomed from all members of the multidisciplinary team, including students. Those abstracts meeting the criteria for publication will be published on the ABCD website.

The closing date for submissions is 11.59pm on Tuesday 18th July 2023. We will endeavour to inform all authors of the outcome by Wed 9th August 2023.

Please make your submission via the on line abstract submission form.

Privacy Policy | Website Terms and Conditions

Address for correspondence: ABCD (Diabetes Care) Ltd, 483 Green Lanes, London, N13 4BS

Telephone: 01675 477602 Email: info@abcd.care

ABCD (Diabetes Care) is a company limited by shares in England and Wales under company number 7270377, whose registered address is Sterling House, 1 Sheepscar Court, Meanwood Road, Leeds LS7 2BB. Diabetes Care Trust (ABCD) is a registered charity number 1139057, a company limited by guarantee in England and Wales under company number 74248361,whose registered address is Sterling House, 1 Sheepscar Court, Meanwood Road, Leeds LS7 2BB. ABCD (Diabetes Care) Ltd is a wholly owned subsidiary of the Diabetes Care Trust (ABCD) Ltd

ABCD Corporate Pharma Sponsors; Gold: Astra Zeneca, Lilly, Sanofi. Silver: A.Menarini Farmaceutica Internazionale SRL,

ABCD Corporate Pump & Device Supporters, Gold: Abbott Laboratories Ltd, Dexcom, GlucoRx, Insulet International Ltd, Ypsomed Ltd; Silver: Air Liquide Healthcare Ltd, Medtrum Ltd, Menarini Diagnostics; Bronze: Roche Diabetes Care.

Read the ABCD statement on pharmaceutical industry funding

Search form

You are here

6th Joint Meeting of ABCD & UKKA - Abstracts

6th Joint Meeting Information